TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Fosamax Case Goes to Jury Lawyers presented closing arguments in one of the first product-liability cases to go trial over Merck's osteoporosis drug Fosamax. online.wsj.com |
BioClinica Acquires Tourtellotte Solutions (Business Wire) NEWTOWN, Pa.----BioClinica, Inc., , a global provider of clinical trial services, today announced that it has acquired privately-held Tourtellotte Solutions, Inc. , a leader in software and services for the bio-pharmaceutical industry. us.rd.yahoo.com |
UCB Helps Students with Crohn's - Video UCB Scholarship Awards Ease Tuition Costs for 31 Students Battling Crohn’s Disease feedproxy.google.com |
Cytokinetics' Market Potential In the news: Cytokinetics (CYTK) has initiated phase I clinical trial to investigate the pharmacokinetic profile of CK-2017357. Cytokinetics has also initiated the second part, or "Part B", of a previously initiated, Phase I clinical trial of CK-2017357 in healthy male volunteers. CK-2017357 is a small molecule drug that offers hope to patients suffering from detrimental and life-threatening muscle wasting and neuromuscular dysfunction. These diseases include amyotrophic lateral sclerosis (ALS), myasthenia gravis, sarcopenia, claudication, cachexia, and shortcomings associated with aging. Complete Story » seekingalpha.com |
ERT to Present at the 28th Annual J.P. Morgan Health Care Conference on January 14, 2010 (PR Newswire) ERT , announced today that Dr. Michael J. McKelvey, the Company's President and CEO, and Keith Schneck, the Company's Executive Vice President and CFO, are scheduled to present at the 28th Annual J.P. us.rd.yahoo.com |